Should you build or buy Pharma MLR / Promotional Material Review (PromoMats)?
Pharma MLR / Promotional Material Review software (commonly called PromoMats) manages the medical-legal-regulatory review cycle for promotional and medical content, tracking claims against approved label language, enforcing fair-balance requirements, versioning materials through review stages, and generating the audit trail required for FDA 2253 submissions.
Copy reviewed 2026-09-19 · Research revision 2026-09-06
Keep the claims library and approved messaging accessible. The latest research identifies vendor-delivered MLR systems and pre-review tools on purchased platforms. That supports a practical split: test internal checks and routing while retaining the controlled review, versioning, and approval record your program needs.
Build it, buy it, or bridge?
When building makes sense
Consider an internal build for pre-review checks, routing, or reporting alongside an approved MLR system. The latest research found vendor deployments rather than named pharmaceutical-company replacements for the MLR core. A document workflow prototype is not equivalent evidence.
When buying makes sense
Buying earns its keep when you need controlled review, approvals, compliant records, versioning, and operating support. Compare the vendor’s coverage with the staff, integrations, and controls an internal option would need. Custom extensions can remain useful without replacing the core.
The desk read
Consider an internal build for pre-review checks, routing, or reporting alongside an approved MLR system. The latest research found vendor deployments rather than named pharmaceutical-company replacements for the MLR core. A document workflow prototype is not equivalent evidence.
Buying earns its keep when you need controlled review, approvals, compliant records, versioning, and operating support. Compare the vendor’s coverage with the staff, integrations, and controls an internal option would need. Custom extensions can remain useful without replacing the core.
Vendors in Pharma MLR / Promotional Material Review (PromoMats)
Each file covers what the product is, its funding history, and when the index last verified it alive.
Frequently asked
What is Pharma MLR / Promotional Material Review (PromoMats) software?
Pharma MLR / Promotional Material Review software manages the medical-legal-regulatory review cycle for promotional and medical content, tracking claims against approved label language, enforcing fair-balance requirements, versioning materials through review stages, and generating the audit trail required for FDA 2253 submissions.
When does building Pharma MLR / Promotional Material Review make sense?
Consider an internal build for pre-review checks, routing, or reporting alongside an approved MLR system. The latest research found vendor deployments rather than named pharmaceutical-company replacements for the MLR core. A document workflow prototype is not equivalent evidence.
When does buying Pharma MLR / Promotional Material Review make sense?
Buying earns its keep when you need controlled review, approvals, compliant records, versioning, and operating support. Compare the vendor’s coverage with the staff, integrations, and controls an internal option would need. Custom extensions can remain useful without replacing the core.
What are the main Pharma MLR / Promotional Material Review vendors?
Representative vendors include Veeva Vault PromoMats, Indegene (NEXT MLR), Vodori (Pepper Flow), Papercurve. B4 Pro includes the category score and the full vendor list.
What is the difference between MLR review and AI pre-screening in pharma?
MLR review is the full medical-legal-regulatory sign-off cycle that promotional materials go through before release, including human review by medical, legal, and regulatory functions. AI pre-screening is an upstream filter that runs promotional claims against label language automatically, flagging likely issues before material reaches the human review queue. Companies are increasingly running these as separate layers, using AI pre-screening to reduce the volume hitting full MLR review.